Skip to content

Mobile based observation of physiotherapy in children with cystic fibrosis

Video based Direct Observation Physiotherapy (VDOP) in children with cystic fibrosis: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036796
Enrollment
92
Registered
2021-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention1: VDOP group: Videos of physiotherapy will be sent and assessed by two independent assessors. They will be corrected telephonically if found incorrect. Control Intervention1: Routine grou

Sponsors

AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children with cystic fibrosis on airway clearance therapy

Exclusion criteria

Exclusion criteria: 1. Non availability of a smart phone/ video capturing device. 2. Non availability of internet facility. 3. Unwilling to send videos for the study. 4. Children on home oxygen therapy.

Design outcomes

Primary

MeasureTime frame
To evaluate the adherence with correct technique for airway clearance therapy in children with cystic fibrosis of 1 month to 18 years of age using video based direct observation physiotherapy (VDOP) approach. Outcome- Ratio (%) between the number of sessions performed daily to the prescribed daily sessions of ACT as reported by self-reported adherence (diary records) in both the groups. Timepoint: To evaluate the adherence with correct technique for airway clearance therapy in children with cystic fibrosis of 1 month to 18 years of age using video based direct observation physiotherapy (VDOP) approach. Outcome- Ratio (%) between the number of sessions performed daily to the prescribed daily sessions of ACT as reported by self-reported adherence (diary records) in both the groups.

Secondary

MeasureTime frame
evaluate 1. Improvement in lung function by spirometry parameters 2. Change in consistency of sputum 3. Number of exacerbations requiring antibiotic usage and/or hospitalization. 4. Clinical improvement 5. Quality of life by revised CF QOL score (Hindi Version) Timepoint: 12 weeks

Countries

India

Contacts

Public ContactSheetal Agarwal

AIIMS

dr.kanaram@gmail.com9868152426

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026